GlassScriptPhysician profile
Mark Jon Pamer
NPI 1184824542
$257,214.31
in general payments reported to CMS, 2019-2025
56 companies · $32K in 2025
The $32K reported for 2025 was more than what 96% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $47K · 2020: $18K · 2021: $20K · 2022: $46K · 2023: $70K · 2024: $23K · 2025: $32K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $96K · Food and Beverage: $16K · Consulting Fee: $7,080 · Travel and Lodging: $5,487 · Education: $552.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $95,991.92 |
| Food and Beverage | $16,441.33 |
| Consulting Fee | $7,080.00 |
| Travel and Lodging | $5,486.74 |
| Education | $551.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mylan Specialty L.P. | $186,651.01 | 2019-2024 | Yupelri, Yupelri |
| Astrazeneca Pharmaceuticals LP | $24,389.01 | 2019-2025 | Airsupra, Tezspire, Breztri |
| Viatris Specialty LLC | $10,873.90 | 2025 | Yupelri |
| Grifols USA, LLC | $10,210.77 | 2019-2025 | Prolastin-C Liquid, Xembify |
| United Therapeutics Corporation | $8,517.38 | 2019-2025 | Tyvaso, Tyvaso, Steen Solution |
| Actelion Pharmaceuticals US, INC. | $2,579.92 | 2019-2025 | Uptravi, Opsumit, Opsynvi |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,333.92 | 2019-2025 | Ofev, Stiolto Respimat, Jascayd |
| Glaxosmithkline, LLC. | $1,282.36 | 2019-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Takeda Pharmaceuticals U.S.A., INC. | $1,273.30 | 2020-2025 | Glassia, Hyqvia, Cuvitru |
| Genzyme Corporation | $1,111.84 | 2019-2025 | |
| Electromed, INC. | $989.48 | 2019-2025 | Smartvest |
| Pfizer INC. | $944.77 | 2020-2025 | |
| Insmed, INC. | $849.12 | 2019-2025 | Arikayce, Brinsupri |
| Regeneron Healthcare Solutions, INC. | $704.60 | 2019-2025 | Dupixent |
| Baxter Healthcare | $407.32 | 2022-2025 | Hillrom - Life 2000 Ventilation System, Hillrom - Vest System Model 105 Home Care, Hillrom - Volara System |
Show all 56 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $370.64 | 2019-2025 | Tezspire |
| Octapharma USA, INC. | $343.28 | 2020-2025 | Panzyga, Octagam Immune Globulin (Human) |
| Paratek Pharmaceuticals, INC. | $265.77 | 2021-2025 | Nuzyra, Xhance |
| Philips North America LLC | $256.97 | 2019-2024 | (Ak6) Vest Therapy |
| Genentech USA, INC. | $232.28 | 2019-2025 | Xolair |
| Sunovion Pharmaceuticals INC. | $214.95 | 2019-2020 | |
| Jazz Pharmaceuticals INC. | $208.31 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $205.67 | 2023-2025 | Winrevair, Capvaxive, Keytruda |
| Advanced Respiratory, INC | $200.25 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $199.90 | 2023-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $194.16 | 2019-2022 | |
| Teva Pharmaceuticals USA, INC. | $192.29 | 2019-2022 | |
| Circassia INC. | $191.38 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $187.00 | 2019-2025 | |
| Vifor Pharma, INC. | $158.16 | 2024-2025 | Zemaira |
| Verona Pharma, INC. | $142.03 | 2025 | Ohtuvayre |
| Janssen Biotech, INC. | $133.96 | 2020-2022 | |
| Medtronic, INC. | $131.61 | 2022 | |
| Shire North American Group INC | $121.69 | 2019 | |
| Mallinckrodt Hospital Products INC. | $121.55 | 2020-2025 | Acthar |
| Csl Behring | $98.49 | 2025 | Hizentra |
| Grifols Shared Services North America, INC. | $88.47 | 2025 | Prolastin-C Liquid |
| Axsome Therapeutics, INC. | $83.81 | 2024-2025 | Sunosi |
| Medline Industries LP | $82.66 | 2019 | |
| Optinose US, INC. | $79.13 | 2020-2025 | |
| Ucb, INC. | $66.81 | 2020-2021 | |
| Mallinckrodt Enterprises LLC | $65.84 | 2019 | |
| Inspire Medical Systems, INC. | $57.91 | 2024-2025 | Inspire |
| Pulmonx Corporation | $53.34 | 2022-2023 | Chartis Catheter, Pulmonx Chartis Tablet Console, Zephyr Delivery Catheter |
| Novo Nordisk INC | $48.27 | 2020 | |
| Lilly USA, LLC | $44.32 | 2022-2025 | Zepbound |
| Recordati_rare_diseases_inc. | $40.44 | 2024 | Sylvant |
| Gilead Sciences, INC. | $32.21 | 2019 | |
| Fisher & Paykel Healthcare INC | $30.41 | 2024 | Fisher & Paykel Healthcare |
| Aurinia Pharma U.S., INC. | $27.97 | 2022 | |
| Abbvie INC. | $23.37 | 2022 | |
| Gc Biopharma USA, INC. | $22.72 | 2025 | Alyglo |
| Atos Medical INC | $22.61 | 2020 | |
| Horizon Therapeutics Plc | $20.59 | 2022 | |
| Sandoz INC. | $18.69 | 2024 | Treprostinil |
| Eisai INC. | $15.70 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Pamer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.